Dr. Reddy’s receives positive CHMP opinion from EMA for AVT03
Dr. Reddy’s Laboratories announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
denosumab
Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
Vevzuo is authorised for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord…
EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Sandoz announces positive results for biosimilar Denosumab
The results came soon after Sandoz confirmed acceptance of licence applications for two other proposed biosimilars
Osteoporosis drug may halve repeat hip replacement procedures: Study
Researchers from the University of Sheffield and Sheffield Teaching Hospitals found the osteoporosis drug, denosumab, could…